Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Coating agent for reducing high blood pressure and its use

A technology of coating agent and high blood pressure, which is applied in the field of coating agent for reducing high blood pressure, can solve the problems that the effect is not as good as that of drug treatment, and the curative effect is not good, and achieve the effect of significant curative effect, easy preparation and use, and blood pressure maintenance

Active Publication Date: 2006-08-23
袁重华
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Other non-drug treatments, such as acupuncture, physical therapy, etc., are not as effective as drug treatments
At present, the physical therapy appliances that can be used by patients for self-treatment, such as antihypertensive watches, antihypertensive belts, blood pressure safes, etc., have poor curative effect, with an average effective rate of 30-40%. Therefore, how to apply modern biological theories and methods to develop new The high blood pressure prevention and treatment products that have no side effects, significant curative effect, safety and reliability, and can be treated by patients themselves are undoubtedly a topic that needs to be researched and explored urgently.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Coating agent for reducing high blood pressure and its use
  • Coating agent for reducing high blood pressure and its use
  • Coating agent for reducing high blood pressure and its use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] cetyl alcohol (C 16 h 34 O) 5

[0039] Lanolin (Adeps Lanae) 4

[0040] lanolin alcohol 4

[0041] white oil 10

[0042] mink oil 20

[0043] Azone (C 8 H35NO) 8.5

[0044] Glyceryl Tristearate (C 57 h 110 o 6 ) 5.5

[0045] Siben-60(C 24 h 46 o 6 ) 4

[0046] Tween-60(C 64 h 126 o 26 ) 2

[0047] Glycerin (C 3 h 8 o 3 ) 5

[0048] Hyaluronic acid (H.A.) 0.5

[0049] Kathon CG (Kathon CG) 0.05

[0050] Indapamide (C 16 h 16 ClN 3 o 3 S) 21.5

[0051] margin is H 2 O, make up to 100.

[0052] Observation: 30 mild and moderate hypertension males: 17 cases, females: 13 cases, total effective rate: 75%, marked rate 50%.

Embodiment 2

[0054] C 21 h 27 N 2 o 3 Cl 20

[0055] C 18 h 19 NO 4 Cl 2 18

[0056] Stearic acid (C 18 h 36 o 2 ) 7

[0057] cetyl alcohol (C 16 h 34 O) 3.5

[0058] Lanolin (Adeps Lanae) 3

[0059] white oil 6

[0060] Laurocaprazine (C 8 h 35 NO) 8

[0061] Isopropyl myristate (C 17 h 34 o 2 ) 5

[0062] Siben-60(C24 h 46 o 6 ) 2.5

[0063] Triethanolamine (C 6 h 15 o 3 N) 2

[0064] Propylene Glycol (C 3 h 8 o 2 ) 6

[0065] Kathon CG 0.05

[0066] margin is H 2 O, make up to 100.

[0067] Clinical observation: 20 cases of mild and moderate hypertension, male: 12 cases, female: 5 cases, total effective rate: 80%, marked rate: 60%.

Embodiment 3

[0069] Propylene Glycol (C 3 h 8 o 2 ) twenty two

[0070] Phenylethyl alcohol (C 8 h 10 O) 0.8

[0071] Ethylparaben (C 9 h 10 o 3 ) 1.5

[0072] cetyl alcohol (C 16 h 34 O) 5

[0073] Stearic acid (C 18 h 36 o 2 ) 6

[0074] Triethanolamine (C 6 h 15 o 3 N) 1.3

[0075] Azone (C 8 h 35 ON) 1.5

[0076] Nifedipine (C 18 h 16 o 6 N 2 ) 18

[0077] Hydrochlorothiazide (C 7 h 8 o 4 N 3 CLS 2 ) 22.5

[0078] C 13 h 24 N 4 o 3 S 23

[0079] Castor Oil 9

[0080] Mink Oil 2.5

[0081] Kathon CG 0.05

[0082] margin is H 2 O top up to 100

[0083] Clinical observation is the same as in Example 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a kind of coating agent for treating hypertension and its use. The medicine includes one or several compounds as active component and some assistant. The present invention has the advantages of obvious curative effect of lowering blood pressure smoothly, high safety and high reliability, convenient use, no side effect, and long effect. The cream, ointment and emulsion products of the present invention may be used in treating various hypertension.

Description

technical field [0001] The invention relates to a body-building product needed for people's physical and mental health to improve their quality of life, in particular to a coating agent for reducing high blood pressure and its application. Background technique [0002] Hypertension is a common disease with a high incidence in all countries in the world, about 10-20%. It is a disease that seriously endangers people's health. It has been clinically proven that hypertension is an important cause of heart failure, renal failure, and stroke. cause. In Asia, cerebrovascular disease disability due to high blood pressure accounts for 11.3% of all fatalities, ranking second only to cancer. There are already 100 million hypertensive patients in our country, and there are 2 million patients in Beijing alone. According to 1995, February 24, Medical Economics reported that 73.4% of patients did not know that they were suffering from high blood pressure. So far, the treatment of hypert...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/404A61K31/517A61K31/40A61K31/403A61K31/433A61K31/4422A61K31/54A61K31/133A61K31/41A61K9/06A61P9/12
Inventor 袁重华雷星刘永清苏小荣
Owner 袁重华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products